<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1-Ethyl-1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I3</bold>). HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>21</sub>H
 <sub>23</sub>N
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 366.17730, found 366.18027. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.08 (s, 1H), 10.09 (s, 1H), 8.92 (s, 1H), 7.67 (dd, 
 <italic>J</italic> = 19.0, 8.7 Hz, 4H), 7.53 (d, 
 <italic>J</italic> = 7.9 Hz, 1H), 7.40 (d, 
 <italic>J</italic> = 8.3 Hz, 1H), 7.18 (s, 1H), 7.13–7.09 (m, 1H), 7.01–6.97 (m, 1H), 4.14 (q, 
 <italic>J</italic> = 7.2 Hz, 2H), 2.73 (t, 
 <italic>J</italic> = 7.4 Hz, 2H), 2.40 (t, 
 <italic>J</italic> = 7.4 Hz, 2H), 1.98–1.93 (m, 2H), 1.33 (t, 
 <italic>J</italic> = 7.2 Hz, 3H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.05, 164.40, 142.35, 136.16, 128.12, 128.07, 127.38, 125.59, 121.38, 119.14, 118.72, 118.66, 113.96, 110.00, 40.45, 36.67, 26.24, 24.66, 15.93 ppm.
</p>
